Research Applications Tirzepatide is used across a range of experimental contexts in the research literature
Saxenda and Wegovy are glucagon-like peptide 1 receptor agonists, or GLP-1 receptor agonists, and Zepbound is a dual agonist, impacting GLP-1 and GIP receptors
Curr Diabetes Rep 7:340347
Additionally, incorporating strength training or muscle-building exercises, under medical guidance, can help you gain lean muscle mass and improve overall body composition
According to the Medicines and Healthcare products Regulatory Agency (MHRA) approved Summary of Product Characteristics (SmPC), belching (eructation) is not specifically listed as a common adverse effect for Ozempic, though it is listed as a 'common' side effect (affecting up to 1 in 10 people) for Wegovy
Responsiveness to intervention: The good news is that visceral fat often responds more readily to weight loss than subcutaneous fat